Back to Search Start Over

Interleukin-9 rescues class switching of Memory B cells derived from Common variable immunodeficiency patients.

Authors :
Chakraborty S
Kumari R
Gupta D
Makharia GK
Ahuja V
Kumar P
Mitra DK
Source :
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2023 Sep; Vol. 254, pp. 109697. Date of Electronic Publication: 2023 Jul 20.
Publication Year :
2023

Abstract

Impaired class switch memory (CSM) B cell formation is the hallmark of common variable immunodeficiency (CVID). Various T cell abnormalities have been observed in CVID patients indicating inadequate T-cell help to B cells. A major setback in understanding its pathogenesis is due to diverse clinical presentation. Therefore, we performed extensive immunological investigation in a cohort of CVID patients with similar clinical findings in order to unravel the T cell dysfunction and its influence on the defective humoral immune response. All recruited CVID patients exhibited B cells in the normal range, but reduced CSM B cells. However, patients showed reduced T cell proliferation, reduced level of serum Interleukin-9 (IL-9) and frequency of IL-9 expressing CD4 (Th-9) cells. IL-9 supplementation along with CD40 engagement was effective in inducing in vitro CSM B cells formation in CVID patients. Thus, IL-9 supplementation has the potential to restore impaired CSM B cell formation in CVID.<br /> (Copyright © 2023 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1521-7035
Volume :
254
Database :
MEDLINE
Journal :
Clinical immunology (Orlando, Fla.)
Publication Type :
Academic Journal
Accession number :
37481011
Full Text :
https://doi.org/10.1016/j.clim.2023.109697